A Phase 2a Study of Benralizumab for Patients with Eosinophilic Asthma in South Korea and Japan

Publisher： Karger

E-ISSN： 1423-0097|169|3|135-145

ISSN： 1018-2438

Source： International Archives of Allergy and Immunology, Vol.169, Iss.3, 2016-04, pp. : 135-145

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Association between Neutrophilic and Eosinophilic Inflammation in Patients with Severe Persistent Asthma

By  

International Archives of Allergy and Immunology, Vol. 137, Iss. 1, 2005-06 ,pp. : 7-11

Karger

Access to resources Recommend Favorite

Identifying clinical correlates for suicide among epilepsy patients in South Korea: A case–control study

By  

EPILEPSIA, Vol. 56, Iss. 12, 2015-12 ,pp. : 1966-1972

John Wiley & Sons Inc

Access to resources Recommend Favorite

Eosinophilic Bronchitis without Asthma

By  

International Archives of Allergy and Immunology, Vol. 147, Iss. 1, 2008-04 ,pp. : 1-5

Karger

Access to resources Recommend Favorite

Risk of tuberculosis in patients treated with anti‐tumor necrosis factor therapy: a nationwide study in South Korea, a country with an intermediate tuberculosis burden

By  

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (ELECTRONIC), Vol. 18, Iss. 3, 2015-03 ,pp. : 323-330

John Wiley & Sons Inc

Access to resources Recommend Favorite

CYT003, a TLR9 agonist, in persistent allergic asthma – a randomized placebo‐controlled Phase 2b study

By  

ALLERGY, Vol. 70, Iss. 9, 2015-09 ,pp. : 1160-1168

John Wiley & Sons Inc

Access to resources Recommend Favorite